HeartSciences (HSCS) Short-Term Debt repayments (2024 - 2025)
HeartSciences posted quarterly Short-Term Debt repayments of $66762.0 for Q4 2025, down 4.2% year-on-year from $69686.0 in Q4 2024, and up 38.91% on a QoQ basis from $48062.0 in Q3 2025.
HeartSciences (HSCS) has 2 years of Short-Term Debt repayments data on file, last reported at $66762.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 259.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | HeartSciences | 4.56 Mn | 1.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 66,762.00 |
| Oct 31, 2025 | 66,762.00 |
| Jul 31, 2025 | 48,062.00 |
| Jul 31, 2025 | 48,062.00 |
| Oct 31, 2024 | 69,686.00 |
| Oct 31, 2024 | 69,686.00 |
| Jul 31, 2024 | 52,063.00 |
| Jul 31, 2024 | 52,063.00 |